China Biologic Products Announces Record Fourth Quarter And Full Year 2009 Results (News-Medical-Net)

TAI’AN, Shandong, China, March 23 /PRNewswire-Asia-FirstCall/ — China Biologic Products, Inc. (Nasdaq: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. (“Taibang”) and Guiyang Dalin Biologic …